Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.66 USD
Change Today +0.0321 / 1.22%
Volume 20.4K
GALT On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 1:55 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Theodore D. Zucconi Ph.D.

Director of Business Development, Galectin Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

68--

Background*

Dr. Theodore D. Zucconi, Ted, Ph.D., serves as Director of Business Development at Pro-Pharmaceuticals Inc. Dr. Zucconi served as the Chief Executive Officer and President of Pro-Pharmaceuticals Inc., from February 12, 2009 to March 16, 2011. Dr. Zucconi served as the President of Implementation Edge. He served as the President of Pro-Pharmaceuticals Inc. from October 2007 to December 31, 2008. Previously, Dr. Zucconi held executive level positions in general management, ...

Read Full Background

Corporate Headquarters*

4960 Peachtree Industrial Boulevard
Norcross, Georgia 30071

United States

Phone: 678-620-3186
Fax: 770-864-1327

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD 1977
State University of New York
BS
Villanova University
MS
University of Connecticut
Master's Degree
Thunderbird School of Global Management

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GALT:US $2.66 USD +0.0321

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GALECTIN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.